Cartesian Therapeutics Inc —— 资产负债表 (NASDAQ:RNAC) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 165.44 M159.88 M165.89 M305.05 M435.02 M296.41 M 负债总额 183.44 M137.36 M72.06 M444.68 M441.82 M422.65 M 权益总额 -18.01 M22.52 M93.83 M-440.18 M-6.8 M-126.24 M 负债及股东权益总额 165.44 M159.88 M165.89 M305.05 M435.02 M296.41 M 总债务 24.79 M25.63 M26.26 M0—— 净债务 -128.13 M-92.77 M-96.68 M-65.96 M——

新闻

Cartesian Therapeutics, Inc. (RNAC) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript

BTIG重申Cartesian Therapeutics股票买入评级,目标价44美元

BTIG reiterates Buy on Cartesian Therapeutics stock, $44 target

瑞穗重申Cartesian Therapeutics评级,看好试验进展

Mizuho reiterates Cartesian Therapeutics stock rating on trial progress

Kyverna Stock: The King Of The CAR-T Autoimmune Revolution (NASDAQ:KYTX)

Cartesian Therapeutics, Inc. (RNAC) Upgraded to Buy: What Does It Mean for the Stock?

Johnson & Johnson Touts Positive Results For Lupus Treatment - Johnson & Johnson (NYSE:JNJ)

2026 Market Outlook: Focus On Pharma For Consistent Returns, Potential Skyrocketing Shares

H.C. Wainwright下调Cartesian Therapeutics股票目标价从40美元至30美元

H.C. Wainwright lowers Cartesian Therapeutics stock price target to $30 from $40

Cartesian: Maintaining Buy Rating For Expansion Of Descartes-08 For Myositis (NASDAQ:RNAC)